Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells
1993
Dexamethasone Reduces uPA mRNA Stability in Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): B.R. Henderson, R.F. Kefford
Primary Institution: University of Sydney
Hypothesis
Dexamethasone induces a short-lived protein that down-regulates uPA RNA levels post-transcriptionally in metastatic tumor cells.
Conclusion
Dexamethasone decreases the stability of uPA mRNA in MAT 13762 rat mammary carcinoma cells.
Supporting Evidence
- Dexamethasone reduced uPA RNA levels from within 1 hour of treatment.
- The drug did not alter the rate of uPA gene transcription.
- Dexamethasone's effect on uPA RNA stability required new protein and RNA synthesis.
- uPA RNA half-life was decreased to about 5.5 hours by dexamethasone.
Takeaway
Dexamethasone is a medicine that helps lower certain RNA levels in cancer cells, which might help control how these cells grow.
Methodology
The study involved treating MAT 13762 cells with dexamethasone and analyzing uPA RNA levels using Northern blotting and other assays.
Limitations
The exact mechanism of how dexamethasone affects uPA RNA stability is not fully understood.
Want to read the original?
Access the complete publication on the publisher's website